3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
10
Neoplasms
5
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
3
Urinary Bladder Neoplasms
2
Solid Tumors
2
Gastrointestinal Neoplasms
2
Gallbladder Neoplasms
2
Cholangiocarcinoma
2
Breast Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Thoracic Neoplasms
1
Solid Tumor
1
Skin Neoplasms
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Pancreatic Neoplasms
1
Pancreatic Adenocarcinoma
1
Ovarian Neoplasms
1
Noonan Syndrome
1
Neoplasms, Unknown Primary
1
Neoplasms, Squamous Cell
1
Neoplasms by Site
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Microsatellite Unstable Colorectal Cancer
1
Lung Neoplasms
1
Lung Diseases
1
Leukemia, Myelomonocytic, Chronic
1
Interventions
X-Rays
5
Phantoms, Imaging
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Nuclear Medicine Department, Hospital
4
Biopsy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
Vemurafenib
2
LY3023414
2
trametinib
1
thymoglobulin
1
fludarabine
1
ensartinib
1
dabrafenib
1
Whole-Body Irradiation
1
Tacrolimus
1
Rituximab
1
Pharmacogenomic Variants
1
Mycophenolic Acid
1
Melphalan
1
Lenalidomide
1
Granulocyte Colony-Stimulating Factor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Histiocytosis, Langerhans-Cell
×
cobimetinib
×
Clear all
No trials found.